{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:10:43Z","timestamp":1774674643656,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Left ventricular hypertrophy (LVH) ultimately leads to heart failure in conditions of increased cardiac pre- or afterload. The bone-derived phosphaturic and sodium-conserving hormone fibroblast growth factor-23 (FGF23) and its co-receptor Klotho have been implicated in the development of uremic LVH. Using transverse aortic constriction (TAC) in gene-targeted mouse models, we examine the role of Fgf23 and Klotho in cardiac hypertrophy and dysfunction induced by pressure overload. TAC profoundly increases serum intact Fgf23 due to increased cardiac and bony <jats:italic>Fgf23<\/jats:italic> transcription and downregulation of Fgf23 cleavage. Aldosterone receptor blocker spironolactone normalizes serum intact Fgf23 levels after TAC by reducing bony <jats:italic>Fgf23<\/jats:italic> transcription. Notably, genetic <jats:italic>Fgf23<\/jats:italic> or <jats:italic>Klotho<\/jats:italic> deficiency does not influence TAC-induced hypertrophic remodelling, LV functional impairment, or LV fibrosis. Despite the profound, aldosterone-mediated increase in circulating intact Fgf23 after TAC, our data do not support an essential role of Fgf23 or Klotho in the pathophysiology of pressure overload-induced cardiac hypertrophy.<\/jats:p>","DOI":"10.1038\/s41598-017-10140-4","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T22:11:49Z","timestamp":1504735909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload"],"prefix":"10.1038","volume":"7","author":[{"given":"Svetlana","family":"Slavic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Modert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarela","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Handschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Baierl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejla","family":"Katica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold G.","family":"Erben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olena","family":"Andrukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"10140_CR1","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein, S. et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation \n                           107, 984\u201391 (2003).","journal-title":"Circulation"},{"key":"10140_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. \n                           322, 1561\u20136 (1990).","journal-title":"N. Engl. J. Med."},{"key":"10140_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","volume":"58","author":"MR Dweck","year":"2011","unstructured":"Dweck, M. R. et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J. Am. Coll. Cardiol. \n                           58, 1271\u20139 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10140_CR4","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez, O. M. et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation \n                           119, 2545\u201352 (2009).","journal-title":"Circulation"},{"key":"10140_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MAI Mirza","year":"2009","unstructured":"Mirza, M. A. I., Larsson, A., Melhus, H., Lind, L. & Larsson, T. E. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis \n                           207, 546\u2013551 (2009).","journal-title":"Atherosclerosis"},{"key":"10140_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ki.2012.327","volume":"83","author":"J \u00c4rnl\u00f6v","year":"2013","unstructured":"\u00c4rnl\u00f6v, J. et al. Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int. \n                           83, 160\u2013166 (2013).","journal-title":"Kidney Int."},{"key":"10140_CR7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova, O. et al. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol. Med. \n                           6, 744\u201359 (2014).","journal-title":"EMBO Mol. Med."},{"key":"10140_CR8","first-page":"229","volume":"33","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova, O. et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. \n                           33, 229\u201346 (2014).","journal-title":"EMBO J."},{"key":"10140_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. \n                           113, 561\u20138 (2004).","journal-title":"J. Clin. Invest."},{"key":"10140_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/jbmr.2527","volume":"30","author":"O Andrukhova","year":"2015","unstructured":"Andrukhova, O., Slavic, S., Od\u00f6rfer, K. I. & Erben, R. G. Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23. J. Bone Miner. Res. \n                           30, 1831\u20139 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"10140_CR11","unstructured":"Yan, L. & Bowman, M. A. H. Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100\/RAGE and FGF23. Inflamm. cell Signal. 1 (2014)."},{"key":"10140_CR12","doi-asserted-by":"publisher","unstructured":"Bansal, S. et al. Spleen contributes significantly to increased circulating levels of fibroblast growth factor23 in response to lipopolysaccharide-induced inflammation. Nephrol. Dial. Transplant gfw376 doi:10.1093\/ndt\/gfw376 (2016).","DOI":"10.1093\/ndt\/gfw376"},{"key":"10140_CR13","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/ndt\/gft523","volume":"29","author":"NA van Venrooij","year":"2014","unstructured":"van Venrooij, N. A. et al. FGF23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol. Dial. Transplant. \n                           29, 1525\u20131532 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"10140_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070775","volume":"8","author":"C Zanchi","year":"2013","unstructured":"Zanchi, C. et al. Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor. PLoS One \n                           8, e70775 (2013).","journal-title":"PLoS One"},{"key":"10140_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature \n                           444, 770\u2013774 (2006).","journal-title":"Nature"},{"key":"10140_CR16","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu, H. et al. Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. \n                           281, 6120\u20133 (2006).","journal-title":"J. Biol. Chem."},{"key":"10140_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.febslet.2004.03.090","volume":"565","author":"A Imura","year":"2004","unstructured":"Imura, A. et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. \n                           565, 143\u2013147 (2004).","journal-title":"FEBS Lett."},{"key":"10140_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(98)00127-6","volume":"424","author":"T Shiraki-Iida","year":"1998","unstructured":"Shiraki-Iida, T. et al. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett. \n                           424, 6\u201310 (1998).","journal-title":"FEBS Lett."},{"key":"10140_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/cvr\/cvv187","volume":"108","author":"R Mencke","year":"2015","unstructured":"Mencke, R. et al. Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue. Cardiovasc. Res. \n                           108, 220\u201331 (2015).","journal-title":"Cardiovasc. Res."},{"key":"10140_CR20","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/01.CIR.0000124224.48962.32","volume":"109","author":"K Takeshita","year":"2004","unstructured":"Takeshita, K. et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation \n                           109, 1776\u201382 (2004).","journal-title":"Circulation"},{"key":"10140_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1681\/ASN.2014040325","volume":"26","author":"J Xie","year":"2015","unstructured":"Xie, J., Yoon, J., An, S.-W., Kuro-o, M. & Huang, C.-L. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate. J. Am. Soc. Nephrol. \n                           26, 1150\u20131160 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10140_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.08.017","volume":"242","author":"VM Brandenburg","year":"2015","unstructured":"Brandenburg, V. M. et al. Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis \n                           242, 483\u2013489 (2015).","journal-title":"Atherosclerosis"},{"key":"10140_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jbmr.5650050508","volume":"5","author":"I Vered","year":"1990","unstructured":"Vered, I., Vered, Z., Perez, J. E., Jaffe, A. S. & Whyte, M. P. Normal left ventricular performance in children with X-linked hypophosphatemic rickets: a Doppler echocardiography study. J. Bone Miner. Res. \n                           5, 469\u201374 (1990).","journal-title":"J. Bone Miner. Res."},{"key":"10140_CR24","doi-asserted-by":"publisher","unstructured":"Takashi, Y. et al. Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy. Endocr. Res. 1\u20136 doi:10.1080\/07435800.2016.1242604 (2016).","DOI":"10.1080\/07435800.2016.1242604"},{"key":"10140_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner, A. et al. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metab. \n                           22, 1020\u20131032 (2015).","journal-title":"Cell Metab."},{"key":"10140_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","volume":"26","author":"M Hesse","year":"2007","unstructured":"Hesse, M., Fr\u00f6hlich, L. F., Zeitz, U., Lanske, B. & Erben, R. G. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol. \n                           26, 75\u201384 (2007).","journal-title":"Matrix Biol."},{"key":"10140_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031376","volume":"7","author":"R Anour","year":"2012","unstructured":"Anour, R., Andrukhova, O., Ritter, E., Zeitz, U. & Erben, R. G. Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo. PLoS One \n                           7, e31376 (2012).","journal-title":"PLoS One"},{"key":"10140_CR28","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1210\/en.2011-1878","volume":"153","author":"C Streicher","year":"2012","unstructured":"Streicher, C. et al. Long-Term Fgf23 Deficiency Does Not Influence Aging, Glucose Homeostasis, or Fat Metabolism in Mice with a Nonfunctioning Vitamin D Receptor. Endocrinology \n                           153, 1795\u20131805 (2012).","journal-title":"Endocrinology"},{"key":"10140_CR29","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman, H. A. et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. \n                           88, 8277\u201381 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10140_CR30","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","volume":"111","author":"VS Tagliabracci","year":"2014","unstructured":"Tagliabracci, V. S. et al. Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc. Natl. Acad. Sci. \n                           111, 5520\u20135525 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10140_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bone.2015.12.055","volume":"84","author":"H Yamamoto","year":"2016","unstructured":"Yamamoto, H. et al. Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition. Bone \n                           84, 120\u2013130 (2016).","journal-title":"Bone"},{"key":"10140_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","volume":"470","author":"B Zhang","year":"2016","unstructured":"Zhang, B. et al. Up-regulation of FGF23 release by aldosterone. Biochem. Biophys. Res. Commun. \n                           470, 384\u2013390 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10140_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1172\/JCI7315","volume":"104","author":"JEJ Schultz","year":"1999","unstructured":"Schultz, J. E. J. et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J. Clin. Invest. \n                           104, 709\u2013719 (1999).","journal-title":"J. Clin. Invest."},{"key":"10140_CR34","doi-asserted-by":"publisher","unstructured":"Hao, H. et al. FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin. Oncotarget doi:10.18632\/oncotarget.11623 (2016).","DOI":"10.18632\/oncotarget.11623"},{"key":"10140_CR35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","volume":"31","author":"M Leifheit-Nestler","year":"2016","unstructured":"Leifheit-Nestler, M. et al. Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol. Dial. Transplant. \n                           31, 1088\u20131099 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"10140_CR36","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","volume":"63","author":"JA Udell","year":"2014","unstructured":"Udell, J. A. et al. Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease. J. Am. Coll. Cardiol. \n                           63, 2421\u20132428 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10140_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/hr.2016.130","volume":"40","author":"M Imazu","year":"2017","unstructured":"Imazu, M. et al. Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure. Hypertens. Res. \n                           40, 181\u2013188 (2017).","journal-title":"Hypertens. Res."},{"key":"10140_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix, J. H. et al. Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals. J. Am. Coll. Cardiol. \n                           60, 200\u2013207 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10140_CR39","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","volume":"161","author":"EN Taylor","year":"2011","unstructured":"Taylor, E. N., Rimm, E. B., Stampfer, M. J. & Curhan, G. C. Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am. Heart J. \n                           161, 956\u2013962 (2011).","journal-title":"Am. Heart J."},{"key":"10140_CR40","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jbmr.1546","volume":"27","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya, N. et al. Mechanism of FGF23 processing in fibrous dysplasia. J. Bone Miner. Res. \n                           27, 1132\u20131141 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"10140_CR41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"S-AM Burnett","year":"2006","unstructured":"Burnett, S.-A. M. et al. Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women. J. Bone Miner. Res. \n                           21, 1187\u20131196 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"10140_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2003","unstructured":"Shimada, T. et al. FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis. J. Bone Miner. Res. \n                           19, 429\u2013435 (2003).","journal-title":"J. Bone Miner. Res."},{"key":"10140_CR43","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"Kawata, T. et al. Parathyroid Hormone Regulates Fibroblast Growth Factor-23 in a Mouse Model of Primary Hyperparathyroidism. J. Am. Soc. Nephrol. \n                           18, 2683\u20132688 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10140_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David, V. et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int. \n                           89, 135\u2013146 (2016).","journal-title":"Kidney Int."},{"key":"10140_CR45","doi-asserted-by":"publisher","first-page":"H1504","DOI":"10.1152\/ajpheart.00331.2014","volume":"307","author":"M Imazu","year":"2014","unstructured":"Imazu, M. et al. Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease. AJP Hear. Circ. Physiol. \n                           307, H1504\u2013H1511 (2014).","journal-title":"AJP Hear. Circ. Physiol."},{"key":"10140_CR46","doi-asserted-by":"crossref","unstructured":"Voelkl, J. et al. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J. Clin. Invest. doi:10.1172\/JCI64093 (2013).","DOI":"10.1172\/JCI64093"},{"key":"10140_CR47","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C. et al. FGF23 induces left ventricular hypertrophy. J. Clin. Invest. \n                           121, 4393\u20134408 (2011).","journal-title":"J. Clin. Invest."},{"key":"10140_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2240","volume":"3","author":"J Xie","year":"2012","unstructured":"Xie, J. et al. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat. Commun. \n                           3, 1238 (2012).","journal-title":"Nat. Commun."},{"key":"10140_CR49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.110.943431","volume":"122","author":"K Toischer","year":"2010","unstructured":"Toischer, K. et al. Differential Cardiac Remodeling in Preload Versus Afterload. Circulation \n                           122, 993\u20131003 (2010).","journal-title":"Circulation"},{"key":"10140_CR50","doi-asserted-by":"crossref","unstructured":"Hung, S.-C., Lai, Y.-S., Kuo, K.-L. & Tarng, D.-C. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J. Am. Heart Assoc. 4 (2015).","DOI":"10.1161\/JAHA.115.001918"},{"key":"10140_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ejhf.465","volume":"18","author":"BA Mohamed","year":"2016","unstructured":"Mohamed, B. A. et al. Molecular and structural transition mechanisms in long-term volume overload. Eur. J. Heart Fail. \n                           18, 362\u2013371 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"10140_CR52","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","volume":"304","author":"CD Touchberry","year":"2013","unstructured":"Touchberry, C. D. et al. FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. AJP Endocrinol. Metab. \n                           304, E863\u2013E873 (2013).","journal-title":"AJP Endocrinol. Metab."},{"key":"10140_CR53","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1210\/mend.16.7.0866","volume":"16","author":"RG Erben","year":"2002","unstructured":"Erben, R. G. et al. Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D. Mol. Endocrinol. \n                           16, 1524\u20131537 (2002).","journal-title":"Mol. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10140-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10140-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:38:26Z","timestamp":1671791906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10140-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10140"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10140-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]},"assertion":[{"value":"15 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11298"}}